MRTX-1719

CAS No. 2630904-45-7

MRTX-1719( —— )

Catalog No. M28288 CAS No. 2630904-45-7

MRTX-1719 is a potent first-in-class selective inhibitor of the PRMT5/MTA complex, with an IC 50 of less than 10 nM in PRMT5/MTA MTAP DEL SDMA cells.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 692 In Stock
5MG 676 In Stock
10MG 911 In Stock
25MG 1511 In Stock
50MG 2074 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    MRTX-1719
  • Note
    Research use only, not for human use.
  • Brief Description
    MRTX-1719 is a potent first-in-class selective inhibitor of the PRMT5/MTA complex, with an IC 50 of less than 10 nM in PRMT5/MTA MTAP DEL SDMA cells.
  • Description
    MRTX-1719 is a potent first-in-class selective inhibitor of the PRMT5/MTA complex, with an IC 50 of less than 10 nM in PRMT5/MTA MTAP DEL SDMA cells.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Chromatin/Epigenetic
  • Target
    Histone Demethylase
  • Recptor
    5-HT2|D2 receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2630904-45-7
  • Formula Weight
    464.88
  • Molecular Formula
    C23H18ClFN6O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (215.11 mM)
  • SMILES
    N#CC1=C(OC2CC2)C=C(Cl)C(F)=C1C3=C(C4=CC5=C(C(NN=C5CN)=O)C=C4)C=NN3C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Kjellberg B, et, al. Partial restoration by a neuroleptic (spiramide) of items of grooming behaviour suppressed by amphetamine. Arch Int Pharmacodyn Ther. 1974 Jul;210(1):61-6.
molnova catalog
related products
  • KDM-IN-6

    KDM-IN-6 is a potent, highly selective and cell-active inhibitor of KDM2A/7A with IC50 of 0.16 and 0.19 uM,respectively.

  • Tazemetostat hydrobr...

    Tazemetostat hydrobromide is a potent and selective EZH2 inhibitor.

  • KDM5-IN-48

    A potent, selective and orally bioavailable KDM5 inhibitor with biochemical IC50 of 15.1, 4.7 and 65.5 nM for KDM5A, KDM5B and KDM5C, respectively.